Lineage Cell Therapeutics Provides End of Year Shareholder Letter
Go back to Lineage Cell Therapeutics Provides End of Year Shareholder Letter| (NYSE: LCTX) | Delayed: 1.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.12 | 52 Week High | $ | |||
| Open | $1.12 | 52 Week Low | $ | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $ | |||
| Volume | 658 | |||||
| (NYSE: LCTX) | Delayed: 1.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.12 | 52 Week High | $ | |||
| Open | $1.12 | 52 Week Low | $ | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $ | |||
| Volume | 658 | |||||

